.svg)
GLP-1 medications like semaglutide have reshaped what medically supported weight loss can look like. With over 70% of American adults having overweight or obesity, access to effective, science-backed tools has never been more important.
That being said, not everyone who is interested in semaglutide will qualify for a prescription. In this guide, we’ll break down the BMI requirements for semaglutide, as well as other factors that will be taken into account to determine eligibility.
What is semaglutide and how does it support weight loss?
Semaglutide is a once-weekly injectable GLP-1 medication used to treat type 2 diabetes and chronic weight management in adults meeting BMI criteria. (It’s also sold under the brand names Ozempic® and Wegovy®.)
Semaglutide works by targeting a single hormone pathway—GLP-1—which plays a key role in appetite and blood sugar regulation.
By activating GLP-1 receptors, semaglutide can help:
- Reduce appetite and cravings
- Quiet food noise
- Increase feelings of fullness
- Slow gastric emptying
- Support blood sugar balance
Clinical trials have shown that semaglutide can lead to significant weight loss (up to 15% of body weight)* when paired with consistent lifestyle support.
How to calculate your BMI
Body mass index (BMI) is a screening tool providers use to estimate body fat. BMI is calculated by taking your weight in kilograms and dividing it by your height in meters squared.
BMI formula: Weight (kg) / height (m2).
You can also use the CDC’s BMI calculator here.
Your BMI will fall into one of four categories, which helps providers assess your metabolic risk:
- Underweight: Under 18.5
- Normal weight: 18.5–24.9
- Overweight: 25–29.9
- Obesity: 30 or higher
While BMI doesn’t tell the full story (it doesn’t account for muscle mass or fat distribution, for instance), it remains the primary clinical benchmark for determining GLP-1 eligibility.
Semaglutide BMI requirements
You may qualify for semaglutide if:
- Your BMI is 30 or higher
- Your BMI is 27 or higher and you have at least one weight-related condition
Weight-related conditions may include:
- Hypertension (high blood pressure)
- High cholesterol
- Prediabetes
- Insulin resistance
- Type 2 diabetes
- Obstructive sleep apnea
- Polycystic ovary syndrome (PCOS)
- Heart disease
Eligibility beyond BMI: Other factors providers consider
While BMI is the baseline requirement for semaglutide treatment, it doesn’t automatically guarantee you a prescription. Your provider will evaluate several other factors as well, including:
- History with weight management, especially prior weight-loss attempts
- Personal medical history
- Family medical history
- Age (only available for adults 18 or older)
Semaglutide treatment is not recommended for the following individuals:
- Pregnant or breastfeeding women
- Those with a personal or family history of medullary thyroid carcinoma or MEN 2
Other medical conditions may affect whether you qualify for semaglutide. Your provider’s goal is to determine not just if you qualify, but if semaglutide is a safe and appropriate fit for your specific situation.
Can you qualify for semaglutide with a lower BMI?
In most cases, semaglutide is not recommended for individuals with a BMI lower than 27.
However, there are exceptions. In certain cases—such as significant insulin resistance or elevated visceral fat—a provider may consider treatment on an individual basis.
If you’re unsure about the best path forward, it’s worth having a conversation with your provider.
What about microdosing semaglutide?
Microdosing refers to lower-than-standard doses of semaglutide with slower increases. This approach may offer overall wellness and healthy aging benefits while potentially reducing the likelihood and severity of side effects.
Important note: Microdosing doesn’t override BMI or eligibility requirements. You will still need to meet the medical criteria for GLP-1 treatment. Microdosing is a dosing strategy, not a way to get around qualification requirements.
Lifestyle support matters, too
Semaglutide isn’t meant to do all the work on its own. The best outcomes occur when medication is combined with intentional lifestyle support, which includes balanced nutrition, regular exercise, and ongoing behavioral guidance. (Learn more about the WHO’s guidelines on the use of GLP-1 treatment here.)
Lifestyle changes that can support you while on semaglutide include:
- Diet rich in protein and fiber
- Regular exercise
- Adequate sleep
- Hydration
- Stress management
For more on making sustainable changes to support your weight-management efforts, see our blog on what it really takes to keep the weight off.
How to qualify for semaglutide through Shed
We keep things simple at Shed. To find out if you qualify for semaglutide, visit tryshed.com and take our 5-minute quiz. Once you’ve answered a few questions about your health history and goals, a licensed provider will look over your answers to determine if you’re a good fit.
If you qualify, your medication will be shipped straight to your home. (Detailed instructions for safe use are included.) Our Member Success Team will be available to answer any questions you have during every phase o your journey.
Go further with a Shed Membership
Weight loss doesn’t have to be a solo journey. A Shed Membership, which includes unlimited provider visits, Shed Community access, Health Coaching, and more, rounds out your weight-loss toolkit to help you get back to being the real you.
Membership is $99/month plus the price of medication. Learn more about the membership here.
FAQs about BMI and semaglutide
What BMI do I need to qualify for semaglutide?
Most patients with a BMI of 30 or higher, or 27 or higher with a weight-related condition, can qualify.
Can I get semaglutide if my BMI is under 27?
Typically no, unless there are specific medical factors that warrant individualized consideration. Address any specific concerns you have with your provider.
Is BMI the only requirement for GLP-1 treatment?
No. Your provider will also assess your medical history, family history, safety risks, current medications, and past experiences with weight loss.
How long does it take to find out if I qualify for semaglutide?
In most cases, eligibility can be determined after an initial consultation with a licensed provider. You can do all of this online through Shed.
This blog is for educational purposes only and is not a substitute for medical advice. Please consult your healthcare provider before starting or changing any medication.
*In clinical trials studying semaglutide and tirzepatide, the average weight loss was 15% and 20%, respectively, when paired with diet and exercise. Results may vary.
Compounded medications are prepared by licensed pharmacies to meet the specific needs of individual patients. These medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. However, they are made in accordance with strict regulatory guidelines. If your clinician determines that a compounded medication is clinically appropriate for you, please be aware that it is not an FDA-approved product.
Wegovy® is a registered trademark of Novo Nordisk. Our compounded medications are not affiliated with, nor endorsed by, Novo Nordisk, and are not reviewed by the FDA for safety or efficacy.
